Literature DB >> 9857030

Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes.

F G Whitby1, G Xia, C M Pickart, C P Hill.   

Abstract

The NEDD8/Rub1 class of ubiquitin-like proteins has been implicated in progression of the cell cycle from G1 into S phase. These molecules undergo a metabolism that parallels that of ubiquitin and involves specific interactions with many different proteins. We report here the crystal structure of recombinant human NEDD8 refined at 1.6-A resolution to an R factor of 21.9%. As expected from the high sequence similarity (57% identical), the NEDD8 structure closely resembles that reported previously for ubiquitin. We also show that recombinant human NEDD8 protein is activated, albeit inefficiently, by the ubiquitin-activating (E1) enzyme and that NEDD8 can be transferred from E1 to the ubiquitin conjugating enzyme E2-25K. E2-25K adds NEDD8 to a polyubiquitin chain with an efficiency similar to that of ubiquitin. A chimeric tetramer composed of three ubiquitins and one histidine-tagged NEDD8 binds to the 26 S proteasome with an affinity similar to that of tetraubiquitin. Seven residues that differ from the corresponding residues in ubiquitin, but are conserved between NEDD8 orthologs, are candidates for mediating interactions with NEDD8-specific partners. One such residue, Ala-72 (Arg in ubiquitin), is shown to perform a key role in selecting against reaction with the ubiquitin E1 enzyme, thereby acting to prevent the inappropriate diversion of NEDD8 into ubiquitin-specific pathways.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9857030     DOI: 10.1074/jbc.273.52.34983

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  89 in total

1.  Creation of a pluripotent ubiquitin-conjugating enzyme.

Authors:  C Ptak; C Gwozd; J T Huzil; T J Gwozd; G Garen; M J Ellison
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

2.  The ubiquitin-like protein HUB1 forms SDS-resistant complexes with cellular proteins in the absence of ATP.

Authors:  Jens Lüders; George Pyrowolakis; Stefan Jentsch
Journal:  EMBO Rep       Date:  2003-11-07       Impact factor: 8.807

3.  Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy.

Authors:  Sam Holmstrom; Mary E Van Antwerp; Jorge A Iñiguez-Lluhi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

4.  Structural analysis of UBL5, a novel ubiquitin-like modifier.

Authors:  Teresa McNally; Qiulong Huang; Richard S Janis; Zhihong Liu; Edward T Olejniczak; Regina M Reilly
Journal:  Protein Sci       Date:  2003-07       Impact factor: 6.725

Review 5.  Characterizing ubiquitination sites by peptide-based immunoaffinity enrichment.

Authors:  Daisy Bustos; Corey E Bakalarski; Yanling Yang; Junmin Peng; Donald S Kirkpatrick
Journal:  Mol Cell Proteomics       Date:  2012-06-23       Impact factor: 5.911

Review 6.  Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy.

Authors:  Tomoaki Tanaka; Tatsuya Nakatani; Tetsu Kamitani
Journal:  Mol Oncol       Date:  2012-01-21       Impact factor: 6.603

7.  Structural determinants for the binding of ubiquitin-like domains to the proteasome.

Authors:  Thomas D Mueller; Juli Feigon
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

8.  Using the ubiquitin-modified proteome to monitor protein homeostasis function.

Authors:  Andrea C Carrano; Eric J Bennett
Journal:  Mol Cell Proteomics       Date:  2013-05-23       Impact factor: 5.911

9.  ISG15 Arg151 and the ISG15-conjugating enzyme UbE1L are important for innate immune control of Sindbis virus.

Authors:  Nadia V Giannakopoulos; Elena Arutyunova; Caroline Lai; Deborah J Lenschow; Arthur L Haas; Herbert Whiting Virgin
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

10.  Saccharomyces cerevisiae ubiquitin-like protein Rub1 conjugates to cullin proteins Rtt101 and Cul3 in vivo.

Authors:  Jose M Laplaza; Magnolia Bostick; Derek T Scholes; M Joan Curcio; Judy Callis
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.